Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Elizabeth L Hougen

CFO at Ionis Pharmaceuticals Inc (IONS)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $21.1M

Reported trades

Filed Stock Type Shares Price Value Since
Mar 18SEC IONSIonis Pharmaceuticals Inc Sell Plan 205,608102,272 held (−67%) $72.38 $14.9M -37.4%
Mar 18SEC IONSIonis Pharmaceuticals Inc Sell Plan 9,44092,832 held (−9%) $72.77 $687K -37.8%
Mar 18SEC IONSIonis Pharmaceuticals Inc Sell Plan 10,17282,660 held (−11%) $73.21 $745K -38.2%
Feb 2SEC IONSIonis Pharmaceuticals Inc Sell 6,988132,881 held (−5%) $83.24 $582K -45.6%
Jan 20SEC IONSIonis Pharmaceuticals Inc Sell 12,922126,307 held (−9%) $75.22 $972K -39.8%
Oct 1SEC IONSIonis Pharmaceuticals Inc Sell Plan 49,800110,500 held (−31%) $65.26 $3.2M -30.6%
  • Sell

    CFO Elizabeth L Hougen sold $14.9M of IONS at $72.38 — cuts the stake by 67%; pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Elizabeth L Hougen sold $687K of IONS at $72.77 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Elizabeth L Hougen sold $745K of IONS at $73.21 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Elizabeth L Hougen sold $3.2M of IONS at $65.26 — cuts the stake by 31%; pre-scheduled 10b5-1 plan sale.